Cryoport expands into biostorage with Cryogene acquisition

By Vassia Barba contact

- Last updated on GMT

(Image: Getty/Yozayo)
(Image: Getty/Yozayo)

Related tags: Cryoport, Logistics, cell and gene therapy, CAR-T

Cryoport acquires Cryogene to gain access to the latter company’s 21,000-square-foot biostorage facility in Houston.

The cold chain logistics firm for the life sciences industry has been looking to add storage services to its offering, Mark Sawicki, Cryoport’s CCO told us ​recently.

The acquisition is structured as an asset purchase and, as stated, it is expected to be immediately accretive to Cryoport's earnings.

The US facility provides storage of biological specimens, materials and samples for clients such as Merck, MD Anderson, Houston Methodist Hospital, Texas Children's Hospital, Mesoblast, Bellicum and Baylor University.

The storage service for biological commodities covers a full range of temperatures, from cryogenic to controlled room temperature, and includes sample inventorying, data sample discrepancy resolution and accessioning samples into its validated data inventory software.

The deal comes after Cryoport expanded the number of its clients recently, including adding Celularity ​to its clients roster.

During the previous year, the company established multiple collaborations ​and boosted its revenue ​by becoming the exclusive distributor of Novartis’ Kymriah​ ​(tisagenlecleucel) and Kite’s Yescarta (axicabtagene ciloleucel), the two approved chimeric antigen receptor (CAR)-T therapies.

Related news

Show more

Related products

show more

High-Density Vero Cell Perfusion Culture

High-Density Vero Cell Perfusion Culture

Eppendorf for Bioprocess – Solutions that grow with you | 01-May-2018 | Application Note

Viral diseases like rabies, rotavirus and influenza are causing many deaths worldwide, resulting in a strong demand for more productive manufacturing techniques...

Related suppliers

Follow us

Products

View more

Webinars